在狼性炎中最佳的葡萄糖皮质类药物治疗
Gabriel Figueroa-Parra1,2, Mario Bautista-Vargas2, Erika Navarro-Mendoza2
1Rheumatology Service, University Hospital "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, México.
概括
葡萄糖皮质类药物是狼性炎 (LN) 的关键,但最佳剂量尚不清楚. 需要进行研究,以平衡疗效和副作用,以便在这种严重的病中改善患者的治疗结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 狼性炎 (LN) 影响到51.7%的全身性红斑狼患者,增加死亡率和末期病风险.
- 由于抗炎作用,葡萄糖皮质类药物一直是LN的主要治疗方法,尽管最佳策略仍在争论中.
- 了解葡萄糖皮质体机制和长期风险对于有效管理LN至关重要.
研究的目的:
- 提供对狼性炎的葡萄糖皮质类药物治疗的深入分析.
- 审查LN中葡萄糖皮质类药物的历史使用,不断变化的剂量策略和机制性途径.
- 探索当前关于疗效,安全性和替代治疗方法的证据.
主要方法:
- 在狼性炎的葡萄糖皮质类药物治疗的综合文献综述.
- 分析历史治疗趋势和当前的剂量策略 (例如,IV脉冲,口服).
- 检查葡萄糖皮质体作用的基因组和非基因组机制.
主要成果:
- 从高剂量转换为联合免疫抑制剂和低剂量葡萄糖皮质体疗法,以减轻不良影响.
- 长期使用葡萄糖皮质醇与包括感染,骨质疏松症,高血糖和心血管疾病在内的重大风险有关.
- 证据支持各种剂量策略,有希望但未经研究的替代方案,如低剂量和无葡萄糖皮质激素的治疗方案.
结论:
- 尽管面临挑战,葡萄糖皮质类药物仍然是狼性炎管理的基石.
- 进一步的研究对于优化葡萄糖皮质激素疗法,完善逐渐缩小和开发更安全的治疗组合至关重要.
- 平衡葡萄糖皮质类药物疗效与毒性对于改善LN患者的治疗结果至关重要.
相关概念视频
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
217
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
217
01:29Inflammatory Bowel Disease IV: Pharmacological Management
111
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
111
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
115
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
115
01:29Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119